HYPERION DEFI, INC. Notes Payable, Current
HYPERION DEFI, INC. (HYPD) had Notes Payable, Current of $8.34 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2026-03-30
- 2025-12-31: Notes Payable, Current $8.34M.
- 2025-09-30: Notes Payable, Current $8.25M.
- 2025-06-30: Notes Payable, Current $8.17M.
- 2025-03-31: Notes Payable, Current $10.79M.
| Period end | Notes Payable, Current |
|---|---|
| 2025-12-31 | $8.34M 10-K · filed 2026-03-30 |
| 2025-09-30 | $8.25M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $8.17M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $10.79M 10-Q · filed 2025-05-19 |
| 2024-12-31 | $10.74M 10-K · filed 2026-03-30 |
| 2024-09-30 | $10.06M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.26M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $8.78M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $5.83M 10-K · filed 2025-04-15 |
| 2023-09-30 | $3.33M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.04M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $2.18M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $416.67K 10-K · filed 2024-03-18 |
| 2021-09-30 | $7.28M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $959.76K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $783.82K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $97.54K 10-Q · filed 2021-11-12 |
| 2020-09-30 | $145.94K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $421.60K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |